跳至主要内容
临床试验/2024-513963-22-00
2024-513963-22-00招募中4 期

Cognitive function after liver transplantation comparing Tacrolimus formulations

Universitaetsklinikum Schleswig-Holstein AöR5 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2024年10月24日最近更新:
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
150
试验地点
5
主要终点
Change in subjective impression of QoL concerning attention/concentration and memory between Screening and visit 3 (6 months) using the FEDA (self-report questionnaire on attention and memory)

研究概览

简要总结

To determine whether once-daily formulation of Tacrolimus (Envarsus ®) improves subjective impression of attention and memory performance compared to twice-daily formulation of Tacrolimus

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Written informed consent
  • Age 20 to 75 years
  • After 12 months post liver transplantation
  • Immunosuppression with a twice daily formulation of Tacrolimus
  • Application of the same active Tacrolimus twice daily formulation ≥3 months
  • At least mild cognitive impairment

排除标准

  • Dialysis treatment during the previous 30 days
  • Deafness and/or blindness
  • Pregnancy/breastfeeding mothers
  • Current participation in another study
  • Every other aspect that, in the eye of investigator, makes the patient unable to comply with study procedures

结局指标

主要结局

Change in subjective impression of QoL concerning attention/concentration and memory between Screening and visit 3 (6 months) using the FEDA (self-report questionnaire on attention and memory)

Change in subjective impression of QoL concerning attention/concentration and memory between Screening and visit 3 (6 months) using the FEDA (self-report questionnaire on attention and memory)

次要结局

  • Cognitive function is assessed using (I) the Trail Making Test – TMT (time criterion), (II) Adaptive Digit Ordering Test – DOT-A (number of correctly sorted digits), (III) Digit Symbol Test – DST (number of correctly sorted items), (IV) Regensburg Stream of Speech Test – RWT (number of correct items), (V) Victoria Stroop Test – VST (time criterion)
  • Quality of life (QoL) is measured using the SF36 (summary score). QoL will be performed during Screening, after 6 and after 12 months.
  • Everyday executive function is measured by BAFQ (assessment by close relative/partner or care provider). BAFQ will be performed during Screening, after 6 and after 12 months.
  • All (serious) adverse events including clinically significant laboratory parameters and relevant liver and kidney functioning parameters are documented at each visit after baseline.

研究者

发起方
Universitaetsklinikum Schleswig-Holstein AöR
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Felix Braun

Scientific

Universitaetsklinikum Schleswig-Holstein AöR

研究点 (5)

Loading locations...

相似试验